Sutro Biopharma, Inc.’s closest tracked peers in the AskCyborg corpus, with each peer’s Cyborg Score (1–10) from a bull-vs-bear AI analyst debate. Highest-scored: Arcus Biosciences (7/10), Fate Therapeutics (4/10), Mersana Therapeutics (4/10).
| Competitor | Cyborg Score | Industry | Why they compete |
|---|---|---|---|
| Arcus Biosciences | 7/10 | Biopharmaceutical - Immuno-oncology & Cancer Therapeutics | Oncology immunotherapy developer |
| Fate Therapeutics | 4/10 | Biopharmaceutical - Cell & Gene Therapy | Oncology immunotherapy competitor |
| Mersana Therapeutics | 4/10 | Biopharmaceutical - Oncology | ADC-focused biotech competitor |
| Inhibrx | ADC development company |
Read the full Sutro Biopharma, Inc. research report.
Cyborg Scores (1–10) are synthesized by AskCyborg’s multi-agent analyst-debate framework across 11 dimensions, recalibrated weekly. How the score works · Methodology.